Target overview
Synonyms
ROR1
Clinically Active Patent Light
ROR1
ROR1 is flagged as clinically active patent light based on 3 active trials across 4 sponsors and 0 patent-density signals in public data. This is a public-data screen, not a legal, clinical, or investment conclusion.
Clinical activity
Public trial footprint
Clinical trials: 4
Active trials: 3
Recruiting trials: 3
Known assets: 0
Sponsor activity
Competitive footprint
Unique sponsors: 4
Top sponsors: Immunome, . | NBE-Therapeutics AG | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical ., .
Tumor types: Advanced Solid Tumor | Solid Malignancies | Hematologic Malignancies
Patent-density signal summary
Patent layer
Signal count: 0
Recent signals: 0
Top assignees: Unknown
Signal types: Unknown
Scores and labels
Deterministic summary
Clinical crowding: 3/5 (Elevated)
Clinical maturity: 1/5 (Phase 1 Only)
Patent density: 0/5 (Low)
Momentum: 2/5 (Watch)
Confidence: High
Limitations
Manual review still matters
This page summarizes public metadata patterns. It does not conclude patent scope, freedom to operate, clinical superiority, or commercial attractiveness.